Skip to content
Search

Latest Stories

NHS Pay Review Body should focus on the pay rates of pharmacists in bands 5-8: PDA

NHS Pay Review Body should focus on the pay rates of pharmacists in bands 5-8: PDA

It also highlighted several workforce challenges that have impacted the recruitment and retention of pharmacists across all areas of pharmacy practice.    

The Pharmacists' Defence Association (PDA) has submitted evidence to the NHS Pay Review Body (PRB), emphasising on the recruitment and retention of NHS pharmacists.


It has urged the PRB to help the NHS achieve two important objectives – ensuring that pharmacists can achieve well-rewarded and the service is viewed as an appealing alternative by student pharmacists.

The PDA suggested that for the NHS to remain competitive, the PRB should focus its pay approach on employees within Bands 5-8 this year.

It recognised that the last recommendation from the PRB was a “flat rate increase” and it left those working in the above-mentioned bands feeling “unhappy”, which led to the CSP taking strike action over pay for the first time in their history.

Consequently, it recommended that this year’s recommendations should be referred to and linked to the 2018 restructuring of the Agenda for Change (AfC) pay bands.

Paul Moloney, PDA Union National Officer said: “The PDA has become increasingly concerned that the Pay Review Body receives no submission specifically related to pharmacists employed under Agenda for Change terms and conditions and we wanted to change that.

“We have therefore produced evidence to show the urgency of ensuring that pharmacists are fairly renumerated for the work they do and acknowledging that for many the purchasing power of their income has fallen over successive years.”

“While we are not arguing for special treatment for our 7,000 members in hospitals, we make a strong case for the PRB to look specifically as the pay bands our members work in and use that analysis as the driving force for this year’s recommendation to government on NHS pay,” he added.

As of 31 December 2023, the General Pharmaceutical Council (GPhC) register listed 64,104 pharmacists, with 54,119 of them located in England.

The PDA highlighted that while the number of registered pharmacists continues to grow “several workforce challenges” have impacted the recruitment and retention of pharmacists across all areas of pharmacy practice.

The workforce-related issues included chronic understaffing, sub-standard working environments, the inability to exercise their professional judgement, an absence of protected training time and experiences of racism, violence and abuse.

According to the Pharmacy Workforce Race Equality Standard (PWRES) report published by NHS England in September 2023, pharmacy team members of Black, Asian and minority ethnic origin experience more “harassment, bullying and abuse, poorer career progression and greater experience of discrimination” than White pharmacy team members.

In a survey conducted by the PDA, around 77 per cent of hospital pharmacists revealed that they were looking to change their career or employment status in the next 12-18 months, citing pressure and mental health concerns and pay as the primary issues

Other concerns were burnout, workplace pressure (not enough resources, skill mix) and dissatisfaction (lack of reward, feeling undervalued and demotivated).

A small number of respondents (four per cent) identified bullying and harassment as their main concerns.

In December 2023, the PDA carried out a separate workforce temperature check of over 2,000 pharmacists working in all areas of practice and it was found that nearly one-third of respondents were looking to leave pharmacy altogether

Approximately two-third of them were required to undertake more non-clinical work due to a lack of support staffing.

Further, the representative body of pharmacists reported that many of its members have chosen to become locum pharmacists to help manage workplace stress and poor mental health.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less